Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Squamous cell carcinoma of the nasal cavity: A descriptive analysis of cases from the head and neck 5000 study

Dale, Oliver T., Pring, Miranda, Davies, Amy, Leary, Sam, Ingarfield, Kate ORCID: https://orcid.org/0000-0002-6910-0267, Toms, Stu, Waterboer, Tim, Pawlita, Michael, Ness, Andy R. and Thomas, Steve J. 2019. Squamous cell carcinoma of the nasal cavity: A descriptive analysis of cases from the head and neck 5000 study. Clinical Otolaryngology 44 (6) , pp. 961-967. 10.1111/coa.13414

Full text not available from this repository.

Abstract

Objectives This paper aims to provide contemporary epidemiological data on squamous cell carcinoma (SCC) of the nasal cavity, which represents a rare type of head and neck cancer. Design, Setting & Participants A descriptive analysis of people with nasal cavity SCC treated with curative intent from the Head and Neck 5000 study; a multicentre clinical cohort study of people from the UK with head and neck cancer. People with tumours of the nasopharynx, paranasal sinuses and other sub‐sites of the head and neck were excluded. Main outcome measures Demographic data and treatment details are presented for all participants. The main outcomes were overall survival and survival according to categories of characteristics (eg, smoker vs non‐smoker); these were explored using Kaplan‐Meier plots. Results Thirty people with nasal cavity SCC were included in the study, of which most were male (67%) and current or ex‐smokers (70%). The majority (70%) presented with early‐stage (T1/2, N0) tumours. Cervical lymph node metastases at presentation were rare, occurring in only one person. Nine people died during the follow‐up period (30%). Worse survival outcomes were seen in people with moderate or severe co‐morbidities. Conclusions This paper provides epidemiological data on nasal cavity SCC in the UK. Patterns of disease and survival outcomes are described, identifying high‐risk groups. Further studies should explore whether primary treatment modality alters survival.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Centre for Trials Research (CNTRR)
Publisher: Wiley
ISSN: 1749-4478
Date of Acceptance: 28 July 2019
Last Modified: 01 Dec 2022 02:06
URI: https://orca.cardiff.ac.uk/id/eprint/130001

Citation Data

Cited 4 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item